GSOR03 Presentation Time: 5:10 PM

IF 1.7 4区医学 Q4 ONCOLOGY

Brachytherapy Pub Date : 2024-10-25 DOI:10.1016/j.brachy.2024.08.049

Santanu Samanta MD , Emily Baker MA , Anam Kesaria MD , Haley Kelly RN , Faraz K. Mahmoudabadi PhD , Gary Lewis MD

{"title":"GSOR03 Presentation Time: 5:10 PM","authors":"Santanu Samanta MD , Emily Baker MA , Anam Kesaria MD , Haley Kelly RN , Faraz K. Mahmoudabadi PhD , Gary Lewis MD","doi":"10.1016/j.brachy.2024.08.049","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose</h3><div>Brachytherapy using HDR plays a crucial role in the treatment of gynecological cancer undergoing radiation therapy. This pilot study examines the use of Virtual Reality (VR) distraction for subjects undergoing HDR brachytherapy and its effects on their satisfaction, procedural anxiety, pain, and the need for analgesics or anxiolytics. We hypothesize that incorporating VR distraction into the brachytherapy treatment workflow will improve subjects’ satisfaction, reduce procedural anxiety and pain, and reduce the need for analgesics or anxiolytics.</div></div><div><h3>Methods and Materials</h3><div>From September 2022 to November 2023, 7 patients have been enrolled so far, each requiring a minimum of 4 sessions of HDR brachytherapy. Each patient underwent 2 sessions with VR and 2 sessions without. Each patient was also asked to fill out a questionnaire before and after each HDR brachytherapy session, which included pain score, and anxiety score among other details. Data including AE events were recorded post-treatment for all sessions.</div></div><div><h3>Results</h3><div>With an accrual goal of 20 patients, 7 women, ages 29 to 81, participated in the study. Six of the subjects were white and 1 subject was black or African American. All 7 subjects attempted to use virtual reality during brachytherapy at least once, contributing to a total of 12 sessions with virtual reality, which were compared to 13 complete sessions without virtual reality. The preliminary results show the following. Subjects reported lower average pre-procedural pain prior to VR sessions. 2. Subjects reported lower average procedural pain during VR sessions. 3. Subjects reported about the same pre-procedural anxiety with or without virtual reality 4. Subjects reported a high satisfaction score and would like to use the VR again.</div></div><div><h3>Conclusions</h3><div>These preliminary results suggest a potential reduction in procedural pain with the inclusion of VR sessions during HDR brachytherapy. However, there was no observed change in the need for opioid or anxiety medications among these initially enrolled patients. All subjects reported high satisfaction scores and would like to use VR again. While many subjects reported it was their first time engaging with VR, in the future, we plan to incorporate a longer demo session and modify the questionnaire to improve the subject's familiarity with the technology.</div></div>","PeriodicalId":55334,"journal":{"name":"Brachytherapy","volume":null,"pages":null},"PeriodicalIF":1.7000,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Brachytherapy","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1538472124001855","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose

Brachytherapy using HDR plays a crucial role in the treatment of gynecological cancer undergoing radiation therapy. This pilot study examines the use of Virtual Reality (VR) distraction for subjects undergoing HDR brachytherapy and its effects on their satisfaction, procedural anxiety, pain, and the need for analgesics or anxiolytics. We hypothesize that incorporating VR distraction into the brachytherapy treatment workflow will improve subjects’ satisfaction, reduce procedural anxiety and pain, and reduce the need for analgesics or anxiolytics.

Methods and Materials

From September 2022 to November 2023, 7 patients have been enrolled so far, each requiring a minimum of 4 sessions of HDR brachytherapy. Each patient underwent 2 sessions with VR and 2 sessions without. Each patient was also asked to fill out a questionnaire before and after each HDR brachytherapy session, which included pain score, and anxiety score among other details. Data including AE events were recorded post-treatment for all sessions.

Results

With an accrual goal of 20 patients, 7 women, ages 29 to 81, participated in the study. Six of the subjects were white and 1 subject was black or African American. All 7 subjects attempted to use virtual reality during brachytherapy at least once, contributing to a total of 12 sessions with virtual reality, which were compared to 13 complete sessions without virtual reality. The preliminary results show the following. Subjects reported lower average pre-procedural pain prior to VR sessions. 2. Subjects reported lower average procedural pain during VR sessions. 3. Subjects reported about the same pre-procedural anxiety with or without virtual reality 4. Subjects reported a high satisfaction score and would like to use the VR again.

Conclusions

These preliminary results suggest a potential reduction in procedural pain with the inclusion of VR sessions during HDR brachytherapy. However, there was no observed change in the need for opioid or anxiety medications among these initially enrolled patients. All subjects reported high satisfaction scores and would like to use VR again. While many subjects reported it was their first time engaging with VR, in the future, we plan to incorporate a longer demo session and modify the questionnaire to improve the subject's familiarity with the technology.

查看原文本刊更多论文

GSOR03 演讲时间：下午 5:10

目的在接受放射治疗的妇科癌症患者中，使用 HDR 近距离放射治疗起着至关重要的作用。本试验研究探讨了在接受 HDR 近距离放射治疗时使用虚拟现实（VR）分散受试者注意力的方法及其对受试者满意度、治疗过程焦虑、疼痛以及镇痛剂或抗焦虑药需求的影响。我们假设，将 VR 转移注意力纳入近距离放射治疗工作流程将提高受试者的满意度，减少程序焦虑和疼痛，并降低对镇痛剂或抗焦虑药的需求。方法和材料从 2022 年 9 月到 2023 年 11 月，迄今已有 7 名患者入组，每名患者至少需要接受 4 次 HDR 近距离放射治疗。每位患者都接受了 2 次有 VR 的治疗和 2 次无 VR 的治疗。每位患者还需在每次 HDR 近距离治疗前后填写一份问卷，其中包括疼痛评分和焦虑评分等详细信息。所有疗程后都记录了包括AE事件在内的数据。结果在20名患者的预期目标下，有7名29至81岁的女性参加了研究。其中 6 名受试者为白人，1 名受试者为黑人或非裔美国人。所有 7 名受试者都在近距离放射治疗过程中尝试使用虚拟现实技术至少一次，共进行了 12 次使用虚拟现实技术的治疗，与 13 次不使用虚拟现实技术的完整治疗进行了比较。初步结果显示如下。受试者在进行虚拟现实治疗前的平均疼痛感较低。2.受试者在虚拟现实治疗过程中的平均疼痛程度较低。3.3. 受试者在使用或不使用虚拟现实技术时，其术前焦虑程度大致相同 4.结论这些初步结果表明，在 HDR 近距离放射治疗过程中加入虚拟现实技术可能会减轻手术疼痛。然而，在这些初步入组的患者中，没有观察到对阿片类药物或焦虑药物的需求有任何变化。所有受试者的满意度都很高，并希望再次使用 VR。虽然许多受试者表示这是他们第一次接触 VR，但我们计划在未来加入更长时间的演示环节并修改问卷，以提高受试者对该技术的熟悉程度。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Brachytherapy 医学-核医学

CiteScore

3.40

自引率

21.10%

发文量

119

审稿时长

9.1 weeks

期刊介绍： Brachytherapy is an international and multidisciplinary journal that publishes original peer-reviewed articles and selected reviews on the techniques and clinical applications of interstitial and intracavitary radiation in the management of cancers. Laboratory and experimental research relevant to clinical practice is also included. Related disciplines include medical physics, medical oncology, and radiation oncology and radiology. Brachytherapy publishes technical advances, original articles, reviews, and point/counterpoint on controversial issues. Original articles that address any aspect of brachytherapy are invited. Letters to the Editor-in-Chief are encouraged.